We recently published a list of Top 9 Latest AI News Updates Investors Shouldn’t Miss. In this article, we are going to take a look at where Amesite Inc. (NASDAQ:AMST) stands against other top latest AI news updates investors shouldn’t miss.

Artificial Intelligence (AI) is already transforming diverse industries, including healthcare, energy, cybersecurity, and communications by boosting productivity, enhancing engagement with clients, and significantly lowering operational overheads.

However, experts believe AI today hasn’t evolved enough to guide scientific processes. As tech giants race to launch AI co-scientist tools to help scientists develop hypotheses and research plans and unravel new knowledge, experts opined that these tools fall short of their promises.

“We’ve seen throughout history that some of the most important scientific advancements, like the development of mRNA vaccines, were driven by human intuition and perseverance in the face of skepticism,” said KhudaBukhsh, assistant professor of software engineering at Rochester Institute of Technology. “AI, as it stands today, may not be well-suited to replicate that.”

While some experts believe these tools could be a good starting point for researchers, the lack of details remains worrisome, raising questions about their potential.

“Those are things that various existing tools are claiming to do, but those are not jobs that I would personally leave up to current AI,” added Lana Sinapayen, an AI researcher at Sony Computer Science Laboratories in Japan. She believes that similar tools focus on the wrong kind of scientific legwork.

We selected AI stocks by reviewing news articles, stock analysis, and press releases. We listed the stocks in ascending order of their hedge fund sentiment taken from Insider Monkey’s database of over 1000 hedge funds.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

Amesite Inc. (NASDAQ:AMST)

Number of Hedge Fund Followers: 1

Amesite Inc. (NASDAQ:AMST) leverages proprietary AI in its NurseMagic solution to optimize documentation workflow, enhance patient communication, and save time for nurses and caregivers. The HIPAA-compliant B2C and B2B solutions help improve operational efficiency, care quality, and overall financial performance in the home care, hospice, and healthcare segments.

On March 5th, Amesite Inc. (NASDAQ:AMST) announced the adoption of its hospice documentation tool, Hospice Notes, in NurseMagic to assist care providers in streamlining accurate documentation for fast and secure reimbursement of charges. The company claims that NurseMagic sales have jumped by over 3,000% in the past three months after it ramped enterprise sales nationally.

“We specifically tuned our models to serve the hospice sector with specialized hospice notes, that focus on capturing patient decline. This function is essential for proper documentation and reimbursements, and our customers tell us that this level of detail not only improves compliance but also saves administrative workload, allowing staff to focus on client care.”

-said Sai Nittala, Senior AI Manager at Amesite Inc.

Overall, AMST ranks 10th on our list of top latest AI news updates investors shouldn’t miss. While we acknowledge the potential of AMST as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than AMST but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

Disclosure: None. This article is originally published at Insider Monkey.